UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2025
Commission File Number: 001-41641
SHL TELEMEDICINE LTD.
(Translation of registrant’s name into English)
90 Yigal Alon Street
Tel Aviv 67891, Israel
(Address of principal executive offices)
_____________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On September 11, 2025, SHL Telemedicine Ltd. (the “Company”) issued a press release titled “SHL announces 2025 half-year results and targets a capital raise”, a copy of
which is furnished herewith as Exhibit 99.1, and which is incorporated by reference herein. The press release contains forward-looking statements and includes cautionary statements identifying important factors that could cause actual results to
differ materially from those in the forward-looking statements.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
SHL TELEMEDICINE LTD.
|
|
| |
|
|
|
| |
By:
|
/s/ Lior Haalman
|
|
| |
|
Lior Haalman
|
|
| |
|
Chief Financial Officer
|
|
| |
|
|
|
September 11, 2025